Enovis Corporation Management to Participate in Upcoming Investor Conferences
Enovis Corporation Management to Participate in Upcoming Investor Conferences
Matt Trerotola, CEO, and Ben Berry, CFO, will represent Enovis during the investor conferences.Enovis Corporation executives will present at upcoming investor conferences, discussing their innovative medical technology solutions.
Enovis Corporation的高管将出席即将举行的投资者会议，讨论他们的创新医疗技术解决方案。
Quiver AI Summary
Quiver AI 摘要
Enovis Corporation, a medical technology growth company, announced its participation in two upcoming investor conferences. Matt Trerotola, the CEO, and Ben Berry, the CFO, will engage in a fireside chat at the Jefferies London Healthcare Conference on November 20, and Berry will also participate in a chat at the Evercore 7th Annual HealthCONx Conference on December 4. Live audio webcasts and replays of these events will be available on the company's website. Enovis focuses on developing innovative solutions for improved patient outcomes and is listed on the NYSE under the symbol ENOV.
医疗技术成长型公司Enovis Corporation宣布参加即将举行的两次投资者会议。首席执行官马特·特雷罗托拉和首席财务官本·贝里将在11月20日的杰富瑞伦敦医疗保健会议上进行炉边交谈，贝瑞还将在12月4日参加Evercore第七届年度HealthConx会议的谈话。这些活动的网络直播和重播将在公司的网站上提供。Enovis专注于开发创新解决方案以改善患者预后，并在纽约证券交易所上市，股票代码为ENOV。
Potential Positives
潜在的积极因素
- Participation in high-profile investor conferences demonstrates the company's commitment to engaging with the investment community and enhancing visibility.
- CEO and CFO participation in fireside chats indicates a strong leadership presence, potentially boosting investor confidence.
- Live audio webcasts and subsequent replays increase accessibility for investors, promoting transparency and engagement.
- Emphasis on innovation and clinical differentiation reinforces the company's position as a forward-thinking leader in the medical technology sector.
- 参加备受瞩目的投资者会议表明了公司对与投资界互动和提高知名度的承诺。
- 首席执行官和首席财务官参与炉边谈话表明了强大的领导力，有可能增强投资者的信心。
- 网络直播和随后的重播增加了投资者的可及性，提高了透明度和参与度。
- 对创新和临床差异化的重视巩固了公司作为医疗技术领域前瞻性领导者的地位。
Potential Negatives
潜在的负面因素
- Management participation in investor conferences may indicate a lack of new product announcements or innovations, which could suggest stagnation in growth or strategy.
- The focus on investor communications rather than product updates may raise concerns among investors about the company's operational performance and future growth prospects.
- 管理层参与投资者会议可能表明缺乏新产品公告或创新，这可能表明增长或战略停滞不前。
- 关注投资者沟通而不是产品更新可能会引起投资者对公司运营业绩和未来增长前景的担忧。
FAQ
常见问题
When will Enovis participate in investor conferences?
Enovis何时会参加投资者会议？
Enovis will participate in the Jefferies London Healthcare Conference on November 20 and the Evercore HealthCONx Conference on December 4.
Enovis将于11月20日参加杰富瑞伦敦医疗保健会议和12月4日的Evercore HealthConx会议。
Who from Enovis will speak at these events?
Enovis的谁将在这些活动上发表演讲？
Matt Trerotola, CEO, and Ben Berry, CFO, will represent Enovis during the investor conferences.
首席执行官马特·特雷罗托拉和首席财务官本·贝里将代表Enovis参加投资者会议。
Where can I find the live webcasts of these events?
在哪里可以找到这些活动的网络直播？
The live audio webcasts will be available on Enovis' website under the Investors tab at Events and Presentations.
网络直播将在Enovis网站上的 “投资者” 选项卡下的 “活动和演讲” 下提供。
What is the focus of Enovis Corporation?
Enovis Corporation 的重点是什么？
Enovis is focused on developing innovative medical technology solutions that improve patient outcomes and enhance operational workflows.
Enovis专注于开发创新的医疗技术解决方案，以改善患者预后并增强操作工作流程。
What is the stock symbol for Enovis Corporation?
Enovis Corporation 的股票代码是什么？
Enovis Corporation is listed on the New York Stock Exchange under the stock symbol ENOV.
Enovis公司在纽约证券交易所上市，股票代码为ENOV。
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
免责声明：这是由人工智能生成的 GlobeNewswire 发布的新闻稿摘要。用于总结此版本的模型可能会出错。在此处查看完整版本。
$ENOV Hedge Fund Activity
$ENOV 对冲基金活动
We have seen 156 institutional investors add shares of $ENOV stock to their portfolio, and 151 decrease their positions in their most recent quarter.
我们已经看到156家机构投资者在其投资组合中增加了$ENOV股票的股票，151家机构投资者在最近一个季度减少了头寸。
Here are some of the largest recent moves:
以下是近期一些最大的走势：
- THRIVENT FINANCIAL FOR LUTHERANS removed 1,579,438 shares (-86.8%) from their portfolio in Q3 2024
- RIVER ROAD ASSET MANAGEMENT, LLC added 1,192,595 shares (+inf%) to their portfolio in Q3 2024
- AMERICAN CENTURY COMPANIES INC added 817,676 shares (+54.1%) to their portfolio in Q3 2024
- CARDINAL CAPITAL MANAGEMENT LLC /CT removed 580,609 shares (-79.9%) from their portfolio in Q2 2024
- BOONE CAPITAL MANAGEMENT LLC removed 562,739 shares (-100.0%) from their portfolio in Q2 2024
- SELECT EQUITY GROUP, L.P. removed 542,565 shares (-97.5%) from their portfolio in Q3 2024
- PRINCIPAL FINANCIAL GROUP INC removed 492,199 shares (-79.1%) from their portfolio in Q3 2024
- ThriVent FINANCIAL FOR LUTHERANS 在 2024 年第三季度从其投资组合中删除了 1,579,438 股股票（-86.8%）
- RIVER ROAD Asset Management, LLC 在 2024 年第三季度在其投资组合中增加了 1,192,595 股股票（+inf%）
- 美国世纪公司在2024年第三季度在其投资组合中增加了817,676股股票（+54.1％）
- CARDINAL CAPITAL Management LLC/Ct在2024年第二季度从其投资组合中删除了580,609股股票（-79.9％）
- 布恩资本管理有限责任公司在2024年第二季度从其投资组合中删除了562,739股股票（-100.0％）
- Select EQUITY GROUP, L.P. 在 2024 年第三季度从其投资组合中删除了 542,565 股股票 (-97.5%)
- 信安金融集团公司在2024年第三季度从其投资组合中删除了492,199股股票（-79.1％）
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
要追踪对冲基金的股票投资组合，请查看Quiver Quantization的机构持股仪表板。
Full Release
完整版本
Wilmington, DE, Nov. 18, 2024 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate in the following investor conferences:
特拉华州威尔明顿，2024年11月18日（GLOBE NEWSWIRE）——创新驱动的医疗技术成长型公司Enovis公司（纽约证券交易所代码：ENOV）今天宣布，其管理团队将参加以下投资者会议：
-
Jefferies London Healthcare Conference:
Matt Trerotola, Chair and Chief Executive Officer, and Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, November 20th at 12:00 p.m. GMT (7:00 a.m. ET)
-
Evercore 7th Annual HealthCONx Conference:
Ben Berry, Chief Financial Officer, will participate in a fireside chat on Wednesday, December 4th at 10:50 a.m. ET.
-
杰富瑞伦敦医疗保健会议：
主席兼首席执行官马特·特雷罗托拉和首席财务官本·贝里将于格林尼治标准时间11月20日星期三中午12点（美国东部时间上午7点）参加炉边谈话
-
Evercore 第七届年度 HealthConx 会议：
首席财务官本·贝瑞将于美国东部时间12月4万亿日星期三上午10点50分参加炉边谈话。
A link to the live audio webcasts, as well as a replay of these events, will be available on the Company's website under the Investors tab at Events and Presentations.
将在公司网站的 “投资者” 选项卡下的 “活动和演讲” 中提供网络直播的链接以及这些活动的重播。
ABOUT ENOVIS
关于 ENOVIS
Enovis Corporation (NYSE: ENOV) is an innovation-driven medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company's extensive range of products, services and integrated technologies fuels active lifestyles in orthopedics and beyond. The Company's shares of common stock are listed in the United States on the New York Stock Exchange under the symbol ENOV. For more information about Enovis, please visit
.
Enovis Corporation（纽约证券交易所代码：ENOV）是一家创新驱动的医疗技术增长公司，致力于开发临床差异化解决方案，以显著改善患者预后并改变工作流程。在持续改进、全球人才和创新的文化的推动下，公司广泛的产品、服务和集成技术为骨科及其他领域的积极生活方式提供了动力。该公司的普通股在美国纽约证券交易所上市，股票代码为ENOV。有关 Enovis 的更多信息，请访问
.
Contact:
联系人：
Kyle Rose
Vice President, Investor Relations
Enovis Corporation
investorrelations@enovis.com
凯尔·罗斯
投资者关系副总裁
Enovis 公司
investorrelations@enovis.com
热门市场机会
热门讨论
热门讨论
